U.S. Osteoarthritis Therapeutics Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Viscosupplements, Platelet-Rich Plasma Therapy, Adipose Tissue Therapy, Bone Graft Substitutes), By Application, By Primary User, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Application
                        1.2.3. Primary User
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Osteoarthritis Therapeutics Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
                        3.3.4. Patent Expiry Analysis
                        3.3.5. Pricing Analysis
Chapter 4. U.S. Osteoarthritis Therapeutics Market: Product Business Analysis
                    4.1. Product Market Share, 2024 & 2033
                    4.2. Product Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    4.4. Viscosupplements
                        4.4.1. Viscosupplements Market, 2021 - 2033 (USD Million)
                    4.5. Platelet-Rich Plasma (PRP) Therapy
                        4.5.1. Platelet-Rich Plasma (PRP) Therapy Market, 2021 - 2033 (USD Million)
                    4.6. Bone Graft Substitutes
                        4.6.1. Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
                    4.7. BMAC (Bone Marrow Aspirate Concentrate) Therapy
                        4.7.1. BMAC (Bone Marrow Aspirate Concentrate) Therapy Market, 2021 - 2033 (USD Million)
                    4.8. Adipose Tissue Therapy
                        4.8.1. Adipose Tissue Therapy Market, 2021 - 2033 (USD Million)
                    4.9. Autologous Chondrocyte Implantation (ACI), Including MACI
                        4.9.1. Autologous Chondrocyte Implantation (ACI), Including MACI Market, 2021 - 2033 (USD Million)
                    4.10. Stem Cell (other)
                        4.10.1. Stem Cell (other) Market, 2021 - 2033 (USD Million)
                    4.11. Others
                        4.11.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. U.S. Osteoarthritis Therapeutics Market: Application Business Analysis
                    5.1. Application Market Share, 2024 & 2033
                    5.2. Application Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by application, 2021 to 2033 (USD Million)
                    5.4. Knee Osteoarthritis
                        5.4.1. Knee Osteoarthritis Market, 2021 - 2033 (USD Million)
                    5.5. Hip Osteoarthritis
                        5.5.1. Hip Osteoarthritis Market, 2021 - 2033 (USD Million)
                    5.6. Shoulder Osteoarthritis
                        5.6.1. Shoulder Osteoarthritis Market, 2021 - 2033 (USD Million)
                    5.7. Spine Osteoarthritis
                        5.7.1. Spine Osteoarthritis Market, 2021 - 2033 (USD Million)
                    5.8. Ankle & Foot Osteoarthritis
                        5.8.1. Ankle & Foot Osteoarthritis Market, 2021 - 2033 (USD Million)
                    5.9. Others
                        5.9.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. U.S. Osteoarthritis Therapeutics Market: Primary User Business Analysis
                    6.1. Primary User Market Share, 2024 & 2033
                    6.2. Primary User Segment Dashboard
                    6.3. Market Size & Forecasts and Trend Analysis, by primary user, 2021 to 2033 (USD Million)
                    6.4. Orthopedic Surgeons
                        6.4.1. Orthopedic Surgeons Market, 2021 - 2033 (USD Million)
                    6.5. Rheumatologists
                        6.5.1. Rheumatologists Market, 2021 - 2033 (USD Million)
                    6.6. Sports Medicine Specialists
                        6.6.1. Sports Medicine Specialists Market, 2021 - 2033 (USD Million)
                    6.7. Regenerative Medicine Specialists
                        6.7.1. Regenerative Medicine Specialists Market, 2021 - 2033 (USD Million)
                    6.8. Others
                        6.8.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. Stryker
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Product Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. Zimmer Biomet Holdings, Inc.
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Product Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. Medtronic
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Product Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Anika Therapeutics, Inc.
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Product Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. Bioventus
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Product Benchmarking
                            7.5.5.4. Strategic Initiatives
                        7.5.6. Vericel Corporation
                            7.5.6.1. Overview
                            7.5.6.2. Financial Performance
                            7.5.6.3. Product Benchmarking
                            7.5.6.4. Strategic Initiatives
                        7.5.7. Smith & Nephew
                            7.5.7.1. Overview
                            7.5.7.2. Financial Performance
                            7.5.7.3. Product Benchmarking
                            7.5.7.4. Strategic Initiatives
                        7.5.8. Fidia Farmaceutici S.p.A.
                            7.5.8.1. Overview
                            7.5.8.2. Financial Performance
                            7.5.8.3. Product Benchmarking
                            7.5.8.4. Strategic Initiatives
                        7.5.9. Seikagaku Corporation
                            7.5.9.1. Overview
                            7.5.9.2. Financial Performance
                            7.5.9.3. Product Benchmarking
                            7.5.9.4. Strategic Initiatives
                        7.5.10. Sanofi
                            7.5.10.1. Overview
                            7.5.10.2. Financial Performance
                            7.5.10.3. Product Benchmarking
                            7.5.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 US osteoarthritis therapeutics market, by product, 2021 - 2033 (USD Million)
Table 4 US osteoarthritis therapeutics market, by application, 2021 - 2033 (USD Million)
Table 5 US osteoarthritis therapeutics market, by primary user, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 U.S. Osteoarthritis therapeutics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 U.S. Osteoarthritis therapeutics market dynamics
Fig. 12 U.S. Osteoarthritis therapeutics market: Porter’s five forces analysis
Fig. 13 U.S. Osteoarthritis therapeutics market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Million)
Fig. 15 Viscosupplements market, 2021 - 2033 (USD Million)
Fig. 16 Platelet-Rich Plasma (PRP) Therapy market, 2021 - 2033 (USD Million)
Fig. 17 Bone Graft Substitutes market, 2021 - 2033 (USD Million)
Fig. 18 BMAC (Bone Marrow Aspirate Concentrate) Therapy market, 2021 - 2033 (USD Million)
Fig. 19 Adipose Tissue Therapy market, 2021 - 2033 (USD Million)
Fig. 20 Autologous Chondrocyte Implantation (ACI), Including MACI market, 2021 - 2033 (USD Million)
Fig. 21 Stem Cell (other) Substitutes market, 2021 - 2033 (USD Million)
Fig. 22 Others market, 2021 - 2033 (USD Million)
Fig. 23 Application market, 2021 - 2033 (USD Million)
Fig. 24 Knee Osteoarthritis market, 2021 - 2033 (USD Million)
Fig. 25 Hip Osteoarthritis market, 2021 - 2033 (USD Million)
Fig. 26 Shoulder Osteoarthritis market, 2021 - 2033 (USD Million)
Fig. 27 Spine Osteoarthritis market, 2021 - 2033 (USD Million)
Fig. 28 Ankle & Foot Osteoarthritis market, 2021 - 2033 (USD Million)
Fig. 29 Others market, 2021 - 2033 (USD Million)
Fig. 30 Primary User market, 2021 - 2033 (USD Million)
Fig. 31 Orthopedic Surgeons market, 2021 - 2033 (USD Million)
Fig. 32 Rheumatologists market, 2021 - 2033 (USD Million)
Fig. 33 Sports Medicine Specialists market, 2021 - 2033 (USD Million)
Fig. 34 Regenerative Medicine Specialists market, 2021 - 2033 (USD Million)
Fig. 35 Others market, 2021 - 2033 (USD Million)